Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

PURPOSE: This open-label, prospective, single-arm, phase II study combined erlotinib with radiation therapy (XRT) and temozolomide to treat glioblastoma multiforme (GBM) and gliosarcoma. The objectives were to determine efficacy of this treatment as measured by survival and to explore the relationsh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Prados, Michael D., Chang, Susan M., Butowski, Nicholas, DeBoer, Rebecca, Parvataneni, Rupa, Carliner, Hannah, Kabuubi, Paul, Ayers-Ringler, Jennifer, Rabbitt, Jane, Page, Margaretta, Fedoroff, Anne, Sneed, Penny K., Berger, Mitchel S., McDermott, Michael W., Parsa, Andrew T., Vandenberg, Scott, James, C. David, Lamborn, Kathleen R., Stokoe, David, Haas-Kogan, Daphne A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2645859/
https://ncbi.nlm.nih.gov/pubmed/19075262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.9639
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak